Certified Specialty Pharmacist (CSP) Exam — Questions and Answers

Question 1: A specialty pharmacist is counseling a patient newly diagnosed with Chronic Myeloid Leukemia (CML) who is starting oral imatinib. Which of the following is a critical counseling point to ensure optimal therapeutic outcomes?

Missed doses should be doubled up at the next scheduled time to maintain efficacy.
Strict adherence to the prescribed regimen is crucial to prevent drug resistance and disease progression. (Correct answer)
It is safe to take over-the-counter antacids concurrently for stomach upset.
The medication can be taken at any time of day, with or without food.

Correct answer: Strict adherence to the prescribed regimen is crucial to prevent drug resistance and disease progression.

Adherence to tyrosine kinase inhibitors (TKIs) like imatinib is paramount for achieving and maintaining response in CML. Non-adherence is strongly correlated with loss of response and disease progression. Imatinib should be taken with a meal and a large glass of water to minimize gastrointestinal irritation. Antacids can decrease absorption and should be spaced out. Doubling up on missed doses is generally not recommended.

Question 2: Under which circumstances is it appropriate for a specialty pharmacy to dispense a specialty medication without a valid, verified prescription?

When the prescriber's office verbally confirms the order over the phone without follow-up documentation for a non-controlled drug
When the drug is commercially available over the counter in the patient's state
When the patient reports the prescription was sent by fax
Under no circumstances — a verified prescription is always required before dispensing (Correct answer)

Correct answer: Under no circumstances — a verified prescription is always required before dispensing

A valid, verified prescription is always required before a specialty pharmacy dispenses a prescription drug, as dispensing without one violates federal and state pharmacy law.

Question 3: When dispensing a specialty medication that requires a Risk Evaluation and Mitigation Strategy (REMS) with Elements to Assure Safe Use (ETASU), which of the following is a mandatory action for the pharmacy?

Provide the patient with a 90-day supply to improve adherence.
Verify that the prescriber and pharmacy are certified in the REMS program before dispensing. (Correct answer)
Enroll the patient in the manufacturer's co-pay assistance program.
Ship the medication exclusively through a single, designated courier.

Correct answer: Verify that the prescriber and pharmacy are certified in the REMS program before dispensing.

REMS programs with ETASU are designed for drugs with significant risks, and they include specific, required interventions beyond standard labeling. A common requirement is that healthcare providers who prescribe and pharmacies that dispense the medication must be specially certified. The dispensing pharmacy has a responsibility to verify its own certification and that of the prescriber before fulfilling the prescription to ensure all safety requirements are met.

Question 4: What is the role of a pharmacist in educating patients about new medications?

Only providing medications during hospital stays.
Filling prescriptions without patient interaction.
Providing clear instructions on the use of medications (Correct answer)
Prescribing new medications.

Correct answer: Providing clear instructions on the use of medications

Pharmacists are the medication experts and play a vital role in educating patients about new medications. This includes explaining the drug's purpose, proper dosage, administration technique, potential side effects, and important drug interactions. Clear, comprehensive instructions ensure patients understand how to use their medication safely and effectively, maximizing therapeutic benefits and minimizing risks.

Question 5: What is the significance of the Drug Enforcement Administration (DEA) in healthcare?

Regulating controlled substances to prevent abuse (Correct answer)
Regulating the use of over-the-counter drugs.
Approving all drugs for market release.
Monitoring the costs of medications.

Correct answer: Regulating controlled substances to prevent abuse

The Drug Enforcement Administration (DEA) is a federal agency responsible for enforcing the controlled substances laws and regulations of the United States. Its primary significance in healthcare is to prevent the diversion and abuse of controlled substances by regulating their manufacturing, distribution, and dispensing. This helps combat drug addiction and illicit drug trafficking.

Question 6: Which of the following best describes a value-based reimbursement model for a specialty medication?

The manufacturer provides a rebate to the payer based on the volume of the drug sold.
The patient's copay is adjusted based on their income level and ability to pay.
The health plan's payment for a medication is partially dependent on the drug achieving specific, pre-defined clinical outcomes for the patient. (Correct answer)
The pharmacy is paid a fixed fee for each prescription dispensed, regardless of the drug's cost.

Correct answer: The health plan's payment for a medication is partially dependent on the drug achieving specific, pre-defined clinical outcomes for the patient.

Value-based contracts, also known as outcomes-based contracts, link financial reimbursement to the actual performance and value a drug delivers to patients. Instead of a simple fee-for-service model, payers, manufacturers, and sometimes providers agree that payment will be tied to achieving specific clinical metrics, such as reduced hospitalizations, improved lab values, or better adherence rates.

Question 7: For a patient with Gaucher disease type 1 starting enzyme replacement therapy (ERT) with imiglucerase (Cerezyme), what is the MOST important pharmacist counseling point regarding administration?

Infusion reactions may occur, and premedication and close monitoring during infusions are recommended (Correct answer)
The drug should be taken with food to improve absorption
The patient must avoid all live vaccines while on therapy
The medication can be self-injected subcutaneously at home without training

Correct answer: Infusion reactions may occur, and premedication and close monitoring during infusions are recommended

Infusion-related reactions are the most common adverse effects of imiglucerase; patients should be informed about symptoms and the importance of premedication and monitoring at the infusion site.

Question 8: How do specialty pharmacists help patients with chronic conditions manage their treatment plans?

Performing diagnostic tests for the disease.
Giving immediate treatment during a crisis.
Managing long-term treatment and ensuring optimal therapy outcomes (Correct answer)
Providing emergency care during hospital visits.

Correct answer: Managing long-term treatment and ensuring optimal therapy outcomes

Specialty pharmacists specialize in complex, high-cost medications for chronic conditions, requiring ongoing management. They provide comprehensive support, including medication education, side effect management, and adherence strategies. This ensures patients achieve the best possible long-term health outcomes, as continuous oversight is essential for chronic disease management.

Question 9: A patient enrolled in the mycophenolate (CellCept/Myfortic) REMS program must be counseled about which primary risk?

Teratogenicity and pregnancy loss (Correct answer)
Hepatic veno-occlusive disease
Serotonin syndrome
QT interval prolongation

Correct answer: Teratogenicity and pregnancy loss

The mycophenolate REMS focuses on teratogenicity; the drug causes pregnancy loss and congenital malformations, requiring females to use contraception and avoid pregnancy.

Question 10: Which federal law governs the licensure requirement for a specialty pharmacy dispensing across state lines?

The Omnibus Budget Reconciliation Act (OBRA) of 1990
The Drug Quality and Security Act (DQSA)
The Food, Drug, and Cosmetic Act (FD&C Act)
Each state's individual pharmacy practice act requiring non-resident licensure (Correct answer)

Correct answer: Each state's individual pharmacy practice act requiring non-resident licensure

Specialty pharmacies shipping medications to patients in other states must obtain non-resident pharmacy licensure in each destination state, as pharmacy practice is regulated at the state level.

Question 11: What does the term 'hub services' refer to in specialty pharmacy?

A pharmacy software platform for managing high-cost medications
Manufacturer-sponsored programs providing patient support, benefits investigation, and PA assistance (Correct answer)
REMS coordination centers operated by the FDA
A centralized distribution warehouse for specialty drugs

Correct answer: Manufacturer-sponsored programs providing patient support, benefits investigation, and PA assistance

Hub services are manufacturer-sponsored patient support programs that assist with benefits verification, prior authorization, copay assistance, and patient education for specific specialty products.

Question 12: When a specialty pharmacy is evaluating a prescription for ataluren (Translarna) for DMD, which condition would make the patient INELIGIBLE for this therapy?

Patient is ambulatory
Age under 5 years
Non-sense mutation in the dystrophin gene (Correct answer)
Concurrent use of oral corticosteroids

Correct answer: Non-sense mutation in the dystrophin gene

Ataluren works specifically for non-sense (stop codon) mutations in the dystrophin gene; patients without this mutation type would not benefit and are not candidates for therapy.

Question 13: What are ETASU in the context of REMS programs?

Enrollment Tracking and Safety Updates
Enhanced Therapy and Safety Utilization
Evaluation Tools and Safety Assessments
Elements to Assure Safe Use (Correct answer)

Correct answer: Elements to Assure Safe Use

ETASU (Elements to Assure Safe Use) are the most restrictive REMS components that can include requirements such as prescriber certification, pharmacy certification, and patient monitoring.

Question 14: According to the 2021 IDSA/SHEA guidelines for an initial episode of non-severe Clostridioides difficile infection (CDI), which of the following is the preferred treatment?

Metronidazole 500 mg orally three times daily for 10 days
Fidaxomicin 200 mg orally twice daily for 10 days (Correct answer)
Vancomycin 125 mg orally four times daily for 10 days
Rifaximin 400 mg orally three times daily for 20 days following a course of vancomycin

Correct answer: Fidaxomicin 200 mg orally twice daily for 10 days

The 2021 focused update from IDSA/SHEA suggests using fidaxomicin over a standard course of vancomycin for an initial CDI episode. This is a conditional recommendation based on moderate certainty of evidence, placing a high value on fidaxomicin's beneficial effects, though vancomycin remains an acceptable alternative.

Question 15: Why is the reimbursement process important in pharmacoeconomics?

It eliminates the need for patient education.
It ensures that providers are paid for services while managing cost-effectiveness (Correct answer)
It decreases healthcare access.
It increases the cost of healthcare.

Correct answer: It ensures that providers are paid for services while managing cost-effectiveness

The reimbursement process is vital in pharmacoeconomics as it determines how healthcare providers and pharmaceutical companies are compensated for services and medications. By linking reimbursement decisions to cost-effectiveness data, payers can ensure that treatments offering good value are covered, while managing overall healthcare expenditures. This mechanism encourages the adoption of efficient and effective therapies while controlling costs.

Question 16: A patient calls the specialty pharmacy saying they cannot afford the required pregnancy test before their next REMS medication refill. What is the pharmacist's most appropriate response?

Dispense a 7-day bridge supply until the patient can obtain the test
Accept the patient's verbal confirmation that she is not pregnant and dispense the medication
Contact the prescriber to request a waiver of the pregnancy testing requirement
Assist the patient in finding low-cost or free testing resources and explain the prescription cannot be dispensed without a confirmed negative test (Correct answer)

Correct answer: Assist the patient in finding low-cost or free testing resources and explain the prescription cannot be dispensed without a confirmed negative test

REMS pregnancy testing requirements are mandatory and cannot be waived; the pharmacist must help the patient access resources while withholding the medication until the test is completed.

Question 17: A patient is being onboarded for a new injectable specialty medication. The patient welcome kit should contain several key informational components. Which of the following is essential to include to ensure patient safety and proper handling?

Instructions for proper disposal of sharps and unused medication. (Correct answer)
The pharmacy's marketing and promotional materials.
A list of pharmacy staff birthdays.
Information on financial assistance programs.

Correct answer: Instructions for proper disposal of sharps and unused medication.

Patient welcome kits must include critical safety information. For injectable medications, this includes clear instructions on how to properly dispose of needles, syringes, and other sharp objects in a designated sharps container to prevent injury and ensure environmental safety. Information on financial assistance is important but secondary to immediate safety instructions.

Question 18: A patient being treated with a direct-acting antiviral (DAA) for HCV calls the specialty pharmacy concerned because they had a quantitative HCV RNA level drawn at week 4 of therapy, and it was still detectable, though low. What is the most appropriate response from the pharmacist?

Recommend doubling the dose of the DAA for the remainder of the treatment course.
Reassure the patient that low-level quantifiable HCV RNA during DAA therapy does not predict treatment failure and to continue the regimen as prescribed. (Correct answer)
Inform the patient this indicates imminent treatment failure and to contact their provider immediately.
Advise the patient to stop therapy, as it is clearly not working.

Correct answer: Reassure the patient that low-level quantifiable HCV RNA during DAA therapy does not predict treatment failure and to continue the regimen as prescribed.

Unlike older interferon-based therapies, on-treatment virologic monitoring is not typically necessary with DAA regimens because a detectable viral load during treatment, especially early on, does not predict failure. The key measure of success is achieving a sustained virologic response (SVR), which is an undetectable viral load 12 weeks after completing therapy.

Question 19: Under iPLEDGE, how many forms of contraception must females of childbearing potential who are not abstinent use while taking isotretinoin?

Three forms of contraception
Contraception is recommended but not mandatory for females
One form of contraception
Two forms of contraception simultaneously (Correct answer)

Correct answer: Two forms of contraception simultaneously

iPLEDGE requires females of childbearing potential to use two simultaneous forms of contraception starting one month before, during, and one month after isotretinoin therapy.

Question 20: How frequently must a REMS sponsor typically submit the first REMS assessment to the FDA after approval?

Every 6 months for the first 2 years
At 18 months, 3 years, and 7 years after approval (Correct answer)
Annually for the first 5 years
Only when a serious adverse event is identified

Correct answer: At 18 months, 3 years, and 7 years after approval

The standard REMS assessment timetable requires submissions at 18 months, 3 years, and 7 years after approval, unless the FDA specifies otherwise.

Question 21: In specialty pharmacy, what does the term 'days supply at risk' refer to?

The number of days a medication has been outside required storage conditions
The days remaining on a pharmacist's DEA registration
The expiration dating window for compounded specialty products
The value of medication inventory that may not be reimbursed due to patient non-adherence or therapy discontinuation (Correct answer)

Correct answer: The value of medication inventory that may not be reimbursed due to patient non-adherence or therapy discontinuation

Days supply at risk quantifies the financial exposure from dispensed medication that a specialty pharmacy may not recover payment for if a patient discontinues therapy or insurance coverage lapses.

Question 22: Which disease-modifying therapy for multiple sclerosis (MS) requires REMS program enrollment due to risks of progressive multifocal leukoencephalopathy (PML)?

Glatiramer acetate (Copaxone)
Natalizumab (Tysabri) (Correct answer)
Dimethyl fumarate (Tecfidera)
Interferon beta-1a (Avonex)

Correct answer: Natalizumab (Tysabri)

Natalizumab (Tysabri) carries a REMS requirement called TOUCH because of the risk of PML, a potentially fatal brain infection caused by JC virus reactivation.

Question 23: In a REMS program that requires a Medication Guide, which party is responsible for distributing it to the patient?

The FDA MedWatch program
The prescribing physician
The drug manufacturer
The dispensing pharmacist or pharmacy (Correct answer)

Correct answer: The dispensing pharmacist or pharmacy

The dispensing pharmacist or pharmacy is responsible for providing the FDA-approved Medication Guide to patients each time a REMS medication is dispensed.

Question 24: A patient is prescribed a specialty medication that is part of a limited distribution network and also has a Risk Evaluation and Mitigation Strategy (REMS) program. What is the primary reason a manufacturer would implement these two restrictions concurrently?

To increase the market price of the medication by creating scarcity.
To ensure enhanced safety monitoring and control over the dispensing process for a high-risk drug. (Correct answer)
To limit the administrative burden on prescribing physicians.
To streamline the prior authorization process with insurance payers.

Correct answer: To ensure enhanced safety monitoring and control over the dispensing process for a high-risk drug.

Manufacturers use limited distribution networks for drugs with complex handling, storage, or administration requirements. When a drug also carries a significant safety risk, an FDA-mandated REMS program is required to ensure the benefits outweigh the risks. Combining these two strategies allows the manufacturer to maintain tight control over the distribution, ensuring that only trained, certified pharmacies dispense the medication and that all safety protocols, such as patient monitoring and education, are strictly followed.

Question 25: Which of the following activities by a specialty pharmacy is the clearest example of potential healthcare fraud?

Enrolling an eligible patient in a manufacturer's copay assistance program to lower their out-of-pocket cost.
Calling a patient for a refill reminder a few days before their medication is due to run out.
Billing an insurer for a brand-name drug using a 'Dispense as Written' code when the generic equivalent was dispensed. (Correct answer)
Conducting a clinical intervention to switch a patient to a more cost-effective, preferred drug on the formulary.

Correct answer: Billing an insurer for a brand-name drug using a 'Dispense as Written' code when the generic equivalent was dispensed.

Fraud involves intentional deception for financial gain. Billing for a more expensive brand-name product when a cheaper generic was dispensed is a form of upcoding and a clear violation. The other options describe legitimate, and often required, functions of a specialty pharmacy: utilizing patient assistance programs, performing clinical management, and promoting adherence.

Question 26: A specialty pharmacy's limited distribution drug (LDD) contract requires it to report dispensing data to the manufacturer monthly. This is BEST described as a requirement of which program type?

REMS program
340B program
Medicaid rebate agreement
Limited Distribution Network (LDN) agreement (Correct answer)

Correct answer: Limited Distribution Network (LDN) agreement

Limited Distribution Network agreements between manufacturers and select specialty pharmacies typically include data reporting obligations as a condition of participation.

Question 27: What does the concept of health technology assessment (HTA) involve?

Testing new drugs for approval.
Evaluating the aesthetic appeal of health products.
Assessing the clinical and economic impacts of health technologies (Correct answer)
Evaluating the cost of healthcare technology only.

Correct answer: Assessing the clinical and economic impacts of health technologies

Health Technology Assessment (HTA) is a multidisciplinary process that systematically evaluates the properties, effects, and impacts of health technologies. This includes assessing their clinical effectiveness, safety, organizational implications, and economic impacts. HTA provides evidence-based information to support decision-making regarding the adoption and use of health technologies within healthcare systems.

Question 28: In accordance with the Drug Supply Chain Security Act (DSCSA), what is a mandatory action for a specialty pharmacy upon receiving a shipment of a prescription drug?

Ensuring receipt of the product's transaction information, history, and statement. (Correct answer)
Reporting the National Drug Code (NDC) of all received products to the FDA.
Sending a sample from the shipment to the manufacturer for quality verification.
Storing the product in a separate, quarantined area for 24 hours before dispensing.

Correct answer: Ensuring receipt of the product's transaction information, history, and statement.

The DSCSA requires dispensers, including pharmacies, to only accept prescription drugs that are accompanied by product tracing documentation, often called the '3Ts': Transaction Information (TI), Transaction History (TH), and Transaction Statement (TS). This documentation must be stored for six years and is crucial for tracing the drug's path through the supply chain to prevent counterfeit or illegitimate products from reaching patients.

Question 29: What is the primary purpose of regulatory compliance in healthcare?

To reduce the need for medications.
To increase healthcare costs.
To ensure patient safety and maintain quality standards (Correct answer)
To make healthcare more profitable.

Correct answer: To ensure patient safety and maintain quality standards

Regulatory compliance in healthcare involves adhering to laws, regulations, and guidelines set by government bodies and professional organizations. Its primary purpose is to protect patients by ensuring that healthcare services, products, and practices meet established safety, efficacy, and quality standards. This minimizes risks and promotes optimal care.

Question 30: What is the purpose of Good Manufacturing Practices (GMP) in the pharmaceutical industry?

To ensure the quality, safety, and consistency of products (Correct answer)
To maximize profits for pharmaceutical companies.
To lower production costs.
To simplify the drug approval process.

Correct answer: To ensure the quality, safety, and consistency of products

Good Manufacturing Practices (GMP) are a set of regulations enforced by agencies like the FDA to ensure that pharmaceutical products are consistently produced and controlled according to quality standards. GMPs cover all aspects of manufacturing, from raw materials to finished products. This guarantees that drugs are safe, pure, and effective, preventing contamination or errors.

Question 31: A Pharmacy Benefit Manager (PBM) is designing its formulary for a competitive therapeutic class, such as inflammatory conditions. To control spending and steer patients towards its preferred biologic agent, which combination of strategies is the PBM most likely to employ?

Offering the same low copay for all drugs in the class to promote patient choice.
Negotiating higher rebates for a preferred product and requiring step therapy through a non-preferred agent first. (Correct answer)
Mandating that all drugs be purchased through the 'buy-and-bill' process.
Eliminating all prior authorization requirements for the entire class.

Correct answer: Negotiating higher rebates for a preferred product and requiring step therapy through a non-preferred agent first.

PBMs use several key strategies to manage specialty drug costs. They negotiate significant rebates from manufacturers in exchange for giving a drug preferred status on their formulary. To enforce this preference, they often implement utilization management tools like step therapy, which requires patients to try and fail on a less expensive or preferred alternative before the more expensive or non-preferred drug will be covered.

Question 32: How do biologic drugs work in disease management?

They block the immune response that causes inflammation (Correct answer)
They increase immune function.
They stimulate rapid cell growth.
They prevent the formation of new blood vessels.

Correct answer: They block the immune response that causes inflammation

Biologic drugs are complex medications derived from living organisms, often targeting specific components of the immune system. In many chronic inflammatory diseases, biologics work by blocking specific proteins or pathways involved in the immune response, thereby reducing inflammation and preventing tissue damage.

Question 33: A specialty pharmacy dispenses a 30-day supply of a high-cost injectable biologic and the patient calls three days later saying it was damaged in transit. What is the BEST course of action?

Ask the patient to return the product before replacement is considered
Immediately replace the shipment, file a carrier claim, and document the incident (Correct answer)
Advise the patient to use the damaged product and report the issue later
Inform the patient that replacement is the prescriber's responsibility

Correct answer: Immediately replace the shipment, file a carrier claim, and document the incident

Specialty pharmacies must ensure patients have uninterrupted therapy; replacing damaged product immediately, filing a carrier claim, and documenting the incident addresses patient safety, financial recovery, and quality reporting.

Question 34: A specialty pharmacist receives a prescription for edaravone (Radicava) for ALS. What is the MOST important logistical consideration for this therapy?

The drug is self-administered orally once daily with no special handling
The prescription requires DEA Schedule II documentation
The drug must be administered at a hospital inpatient unit
The therapy requires IV infusion in cycles and coordination with an infusion center or home infusion service (Correct answer)

Correct answer: The therapy requires IV infusion in cycles and coordination with an infusion center or home infusion service

Edaravone is administered as IV infusions in 28-day cycles (10 infusions per cycle initially); the specialty pharmacy must coordinate with infusion centers or home infusion providers for ongoing access.

Question 35: How does a pharmacist assist with patient counseling for chronic conditions?

By only filling prescriptions.
By offering emergency care.
By prescribing new treatments.
By providing medication and lifestyle management advice (Correct answer)

Correct answer: By providing medication and lifestyle management advice

Specialty pharmacists go beyond simply dispensing medication; they are critical educators and counselors for patients with chronic conditions. They provide detailed information on medication use, potential side effects, and adherence strategies. Additionally, they offer guidance on lifestyle modifications that can significantly impact disease management and overall well-being, supporting long-term health holistically.

Question 36: What role do pharmaceutical manufacturers play in pharmacoeconomics?

They provide treatment recommendations.
They administer health insurance plans.
They provide cost data and support drug development (Correct answer)
They regulate healthcare pricing.

Correct answer: They provide cost data and support drug development

Pharmaceutical manufacturers play a critical role in pharmacoeconomics by conducting and funding studies that generate cost-effectiveness data for their products. They provide essential cost data related to drug development, production, and distribution, which is crucial for economic evaluations. This information helps demonstrate the value of new drugs to payers and healthcare systems, supporting market access and reimbursement decisions.

Question 37: A patient being treated with a direct-acting antiviral (DAA) for Hepatitis C has a Proportion of Days Covered (PDC) of 70% during their 12-week treatment course. This level of adherence is most strongly associated with which of the following outcomes?

A significantly increased risk of virologic failure. (Correct answer)
An increased likelihood of developing medication resistance.
A guaranteed sustained virologic response (SVR).
A lower overall cost of therapy due to missed doses.

Correct answer: A significantly increased risk of virologic failure.

Achieving a sustained virologic response (SVR), or a cure, with DAA therapy is highly dependent on near-perfect adherence. A PDC of 70% constitutes significant non-adherence and dramatically increases the risk of treatment failure, where the virus is not eradicated from the body. While resistance is a concern, the most direct and likely outcome is failing to achieve a cure.

Question 38: What role does a pharmacist play in managing specialty drug therapies?

Administering medications to patients.
Monitoring patients for side effects and ensuring adherence (Correct answer)
Performing surgery to treat conditions.
Prescribing new medications.

Correct answer: Monitoring patients for side effects and ensuring adherence

Specialty pharmacists manage complex drug regimens, which often involve potent medications with significant side effects. Their role is crucial in actively monitoring patients for adverse reactions and providing education and support. This ensures consistent medication use, which is vital for therapeutic success and patient safety.

Question 39: When a new REMS element is added to an existing REMS program, how should a specialty pharmacy respond?

Update internal SOPs and staff training to reflect the new requirements before continuing to dispense (Correct answer)
Wait for the manufacturer to update the pharmacy's certification automatically
Notify patients but continue dispensing under the prior protocol
Continue dispensing under the original REMS terms until the next contract renewal

Correct answer: Update internal SOPs and staff training to reflect the new requirements before continuing to dispense

Pharmacies must update their SOPs and train staff on any modifications to a REMS program before continuing to dispense, as new requirements are binding upon implementation.

Question 40: A specialty pharmacy employee accidentally sends an email containing a patient's PHI to an incorrect recipient. The pharmacy immediately contacts the recipient, confirms the email was deleted, and performs a risk assessment. The assessment concludes there is a low probability of compromise because the recipient is a known business associate under a BAA who acted in good faith and did not further disclose the information. According to the HIPAA Breach Notification Rule, what is the pharmacy's required action?

Report the incident to the Office for Civil Rights (OCR) immediately.
Document the incident and the risk assessment; no formal notification is required. (Correct answer)
Notify the patient and the media within 60 days.
Offer complimentary credit monitoring to the affected patient for one year.

Correct answer: Document the incident and the risk assessment; no formal notification is required.

An impermissible disclosure of PHI is presumed to be a breach unless the covered entity can demonstrate a 'low probability that the PHI has been compromised' through a documented, four-factor risk assessment. If the assessment concludes a low probability of compromise, the event is not considered a reportable breach, and notification to the patient or HHS is not required. However, the entity must maintain documentation of the incident and the risk assessment that led to this conclusion.

Question 41: A patient receiving chemotherapy for colon cancer develops Grade 2 mucositis. Which of the following interventions would be an appropriate supportive care recommendation from the specialty pharmacist?

Initiate prophylactic systemic antibiotics.
Prescribe a potent opioid analgesic like fentanyl.
Advise a bland, soft diet and a 'magic mouthwash' containing lidocaine. (Correct answer)
Immediately hold the next cycle of chemotherapy.

Correct answer: Advise a bland, soft diet and a 'magic mouthwash' containing lidocaine.

For Grade 2 mucositis, management focuses on symptomatic relief to maintain oral intake. A bland, soft diet avoids irritation, and topical anesthetics like lidocaine, often part of a 'magic mouthwash' formulation, can relieve pain. Opioids may be needed for severe (Grade 3-4) pain. Systemic antibiotics are not indicated unless there is a secondary infection. Holding chemotherapy is generally reserved for more severe, life-threatening toxicities.

Question 42: What is the significance of cost-effectiveness analysis in pharmacoeconomics?

It allows healthcare providers to compare the cost and benefit of treatments (Correct answer)
It helps reduce the cost of healthcare administration.
It decreases the availability of medications.
It simplifies the prescription process.

Correct answer: It allows healthcare providers to compare the cost and benefit of treatments

Cost-effectiveness analysis is crucial in pharmacoeconomics because it provides a structured method for comparing the costs of different treatments with their respective health outcomes. By quantifying the benefits (e.g., life-years gained, symptom reduction) against the financial outlay, healthcare providers and policymakers can make evidence-based decisions. This ensures that resources are allocated to interventions that offer the greatest health benefit for the cost.

Question 43: For a patient with Pompe disease receiving alglucosidase alfa (Lumizyme), the specialty pharmacist notes that the patient has developed high and sustained antibody titers. What is the MOST appropriate clinical action?

Double the infusion dose to overcome the antibody effect
Switch to a generic version of the enzyme replacement therapy
Discontinue the enzyme replacement therapy permanently
Notify the prescriber, as high antibody titers can reduce drug efficacy and immune tolerance protocols may be needed (Correct answer)

Correct answer: Notify the prescriber, as high antibody titers can reduce drug efficacy and immune tolerance protocols may be needed

High sustained antibody titers against alglucosidase alfa are associated with reduced clinical response; the prescriber should be notified so immune tolerance induction strategies can be considered.

Question 44: A patient with rheumatoid arthritis, who has failed methotrexate monotherapy, is being started on a Janus kinase (JAK) inhibitor. Which of the following represents a class-wide black box warning for JAK inhibitors that the specialty pharmacist must counsel the patient on?

Increased risk of serious infections, malignancy, and thrombosis (Correct answer)
Severe infusion-related reactions
New or worsening heart failure
Progressive multifocal leukoencephalopathy (PML)

Correct answer: Increased risk of serious infections, malignancy, and thrombosis

The FDA has required a class-wide black box warning for Janus kinase (JAK) inhibitors used for chronic inflammatory conditions. This warning includes an increased risk of serious infections, malignancies (like lymphoma and lung cancer), major adverse cardiovascular events (MACE), and thrombosis. While other warnings exist for different drug classes, this specific combination of risks is characteristic of the JAK inhibitor class warning.

Question 45: For patients with Fabry disease receiving agalsidase beta (Fabrazyme), which adverse effect requires pharmacist patient education BEFORE each infusion?

Infusion-associated reactions including fever, chills, hypertension, and urticaria (Correct answer)
Severe hepatotoxicity requiring liver function monitoring
Photosensitivity requiring sunscreen application
Nephrotoxicity requiring dose adjustment based on eGFR

Correct answer: Infusion-associated reactions including fever, chills, hypertension, and urticaria

Infusion-associated reactions are among the most common adverse effects with agalsidase beta; patients should be premedicated and counseled to report symptoms such as fever, chills, and skin reactions during infusion.

Question 46: What is the primary function of a specialty pharmacy's patient assistance program (PAP) coordination service?

To help financially eligible patients access free or reduced-cost specialty medications from manufacturers (Correct answer)
To bill Medicare Part D on behalf of the patient
To negotiate lower drug acquisition costs for the pharmacy
To substitute brand drugs with less expensive biosimilars

Correct answer: To help financially eligible patients access free or reduced-cost specialty medications from manufacturers

PAP coordination connects patients who meet manufacturer income and insurance eligibility criteria with free or reduced-cost medication programs to eliminate financial barriers to specialty therapy.

Question 47: How do the Centers for Medicare & Medicaid Services (CMS) impact regulatory compliance?

They approve drugs for market release.
They manage healthcare facility construction.
They regulate healthcare providers' pricing strategies.
They ensure compliance with Medicare and Medicaid standards (Correct answer)

Correct answer: They ensure compliance with Medicare and Medicaid standards

The Centers for Medicare & Medicaid Services (CMS) administer the Medicare and Medicaid programs, which provide health coverage to millions of Americans. CMS impacts regulatory compliance by setting and enforcing standards for healthcare providers and organizations that participate in these programs. This ensures quality of care, proper billing, and adherence to federal guidelines.

Question 48: What is the first step in patient counseling for a newly diagnosed disease?

Listening to the patient and explaining treatment options (Correct answer)
Providing medication without discussion.
Discussing the cost of treatment.
Prescribing medications immediately.

Correct answer: Listening to the patient and explaining treatment options

The first step in patient counseling for a newly diagnosed disease is to establish trust and understand the patient's perspective, concerns, and existing knowledge. By actively listening, the pharmacist can then tailor explanations of the disease and treatment options to the patient's individual needs. This fosters engagement and informed decision-making, establishing a foundational patient-centered approach.

Question 49: What is the role of motivational interviewing in patient counseling?

It discourages patients from making decisions.
It helps patients make informed choices by addressing their motivations (Correct answer)
It forces patients to follow treatment plans.
It focuses only on changing patient behavior.

Correct answer: It helps patients make informed choices by addressing their motivations

Motivational interviewing is a patient-centered counseling approach that helps individuals explore and resolve ambivalence about behavior change. In pharmacy, it empowers patients to identify their own reasons for adhering to therapy or making lifestyle changes, fostering intrinsic motivation rather than imposing solutions. This collaborative approach leads to more sustainable and informed health decisions.

Question 50: What is the importance of pharmacogenomics in specialty drug therapy?

It helps personalize treatment for better outcomes (Correct answer)
It is unnecessary in drug therapy.
It replaces the need for medical interventions.
It makes drugs more affordable.

Correct answer: It helps personalize treatment for better outcomes

Pharmacogenomics studies how an individual's genes affect their response to drugs. In specialty drug therapy, this information allows pharmacists to predict drug efficacy and potential adverse reactions, enabling personalized medication selection and dosing. This tailored approach optimizes treatment outcomes, minimizes side effects, and improves patient safety.

Question 51: A CSP is counseling a patient newly prescribed fingolimod (Gilenya) for relapsing MS. Which assessment must be completed BEFORE the first dose?

Colonoscopy to assess GI tolerability
Bone mineral density scan
Pulmonary function testing
Cardiac evaluation including ECG and first-dose observation for bradycardia (Correct answer)

Correct answer: Cardiac evaluation including ECG and first-dose observation for bradycardia

Fingolimod causes bradycardia and AV block with the first dose; an ECG is required beforehand and patients must be observed for at least 6 hours after the first dose for cardiac effects.

Question 52: A patient is starting on a new injectable specialty medication that requires refrigeration. During the final dispensing check, the pharmacist is reviewing the contents of the shipment. In addition to the medication, ancillary supplies, and patient education materials, what other critical item should be included in the patient's first shipment?

A return label for unused medication.
A sharps container for proper needle disposal. (Correct answer)
A detailed invoice for the full cost of the drug.
A list of alternative, non-injectable medications.

Correct answer: A sharps container for proper needle disposal.

Patient safety is paramount in specialty pharmacy. When dispensing an injectable medication, it is the pharmacy's responsibility to provide the means for safe disposal of needles and syringes. Including a sharps container in the first shipment ensures the patient can immediately and properly dispose of biohazardous waste, preventing accidental needlesticks and protecting the community.

Question 53: A specialty pharmacy's quality assurance program identifies a trend of incorrect dosing for a weight-based biologic. What is the MOST systematic corrective action?

Discontinue dispensing the biologic until the issue resolves
Report the errors to the FDA and wait for guidance
Retrain individual pharmacists identified in the errors
Implement a mandatory pharmacist double-check workflow and update the dispensing system to prompt weight-based dose verification (Correct answer)

Correct answer: Implement a mandatory pharmacist double-check workflow and update the dispensing system to prompt weight-based dose verification

Systematic corrective actions such as workflow redesign and system-level prompts address root causes more effectively than individual retraining alone, reducing recurrence across the entire organization.

Question 54: How can a pharmacist help improve medication adherence in patients with complex regimens?

By simplifying regimens and providing reminders (Correct answer)
By prescribing more medications.
By telling patients to skip doses.
By reducing the number of doctor visits.

Correct answer: By simplifying regimens and providing reminders

Complex medication regimens are a significant barrier to adherence. Specialty pharmacists can improve adherence by working with prescribers to simplify dosing schedules, consolidate medications, or suggest alternative formulations. Additionally, they can provide tools like pill organizers, medication calendars, or digital reminders to help patients remember to take their medications consistently.

Question 55: Which therapy for Duchenne muscular dystrophy (DMD) requires a specific exon-skipping amenable mutation for eligibility, making genetic testing essential before dispensing?

Corticosteroids (prednisone)
ACE inhibitors for cardiac protection
Eteplirsen (Exondys 51) (Correct answer)
Creatine supplementation

Correct answer: Eteplirsen (Exondys 51)

Eteplirsen is indicated specifically for patients with a confirmed mutation amenable to exon 51 skipping; genetic testing is mandatory to confirm eligibility before the specialty pharmacy can process the prescription.

Question 56: A specialty pharmacist is dispensing a medication for which the patient's insurance has issued a prior authorization denial. The denial states 'step therapy requirements not met.' Which of the following is the most appropriate next step for the pharmacist to take?

Advise the patient to switch to a different insurance plan.
Inform the patient that they will have to pay the full cash price for the medication.
Contact the prescriber to discuss the denial and assist in appealing or providing clinical rationale for the prescribed drug. (Correct answer)
Dispense a 7-day supply of the medication while the issue is resolved.

Correct answer: Contact the prescriber to discuss the denial and assist in appealing or providing clinical rationale for the prescribed drug.

When a prior authorization is denied due to step therapy, it means the insurer requires the patient to try one or more preferred, often lower-cost, alternative medications first. The specialty pharmacist's role is to collaborate with the prescriber. This involves communicating the reason for denial and working with the prescriber's office to either submit an appeal with clinical justification for bypassing step therapy (e.g., contraindication, history of failure with the preferred agent) or to select an appropriate alternative.

Question 57: What does the FDA's role in drug approval include?

Setting drug prices.
Regulating hospital staff.
Evaluating drug safety, effectiveness, and manufacturing standards (Correct answer)
Only approving the price of drugs.

Correct answer: Evaluating drug safety, effectiveness, and manufacturing standards

The FDA's role in drug approval is comprehensive, involving a thorough review process. This includes evaluating extensive clinical trial data to determine if a drug is safe and effective for its intended use. Additionally, the FDA inspects manufacturing facilities to ensure they meet strict quality and production standards, with this multi-faceted assessment protecting public health.

Question 58: A CSP is counseling the caregiver of a child with spinal muscular atrophy who will receive onasemnogene abeparvovec (Zolgensma). Which statement about this gene therapy is MOST accurate?

It is a one-time IV gene therapy that requires corticosteroid pretreatment to prevent liver toxicity (Correct answer)
The drug is indicated for children over 12 years of age only
The patient must receive the therapy at a specialty pharmacy infusion suite
The therapy is administered as a weekly subcutaneous injection for life

Correct answer: It is a one-time IV gene therapy that requires corticosteroid pretreatment to prevent liver toxicity

Zolgensma is a single-dose IV gene therapy; corticosteroid pretreatment and monitoring are required due to the risk of acute liver injury associated with adeno-associated virus vector delivery.

Question 59: Which of the following is a primary role of a specialty pharmacist in managing patients on oral chemotherapy?

Administering intravenous supportive care medications in the clinic.
Proactively monitoring for and managing treatment-related adverse events and adherence. (Correct answer)
Prescribing the initial oral chemotherapy regimen.
Performing diagnostic imaging to assess tumor response.

Correct answer: Proactively monitoring for and managing treatment-related adverse events and adherence.

A key function of a specialty pharmacist in oncology is the ongoing management of patients on oral anticancer agents. This includes proactive patient education, monitoring for side effects, managing toxicities, assessing adherence, and communicating with the provider to optimize therapy. Prescribing, administering IV drugs, and ordering imaging are typically outside the pharmacist's scope of practice.

Question 60: A specialty pharmacist is counseling a patient who expresses ambivalence about starting a new oral medication for multiple sclerosis due to a fear of potential side effects. Which of the following statements best exemplifies the use of Motivational Interviewing (MI)?

"It sounds like you're concerned about how the side effects might impact your daily life, but you're also hopeful this could prevent a relapse. Could we talk more about that balance?" (Correct answer)
"If you experience a side effect, just call us and we will tell you what to do. Now, let's review the injection instructions."
"Many other patients have had the same fear, but they were fine. Let me show you the statistics on how rarely these side effects occur."
"You must take this medication as prescribed. The risk of disease progression is far worse than any potential side effects."

Correct answer: "It sounds like you're concerned about how the side effects might impact your daily life, but you're also hopeful this could prevent a relapse. Could we talk more about that balance?"

This statement uses a key MI technique called a "double-sided reflection." It acknowledges and validates the patient's concerns (the "con" of taking the medication) while also reflecting their potential motivation for taking it (the "pro"), encouraging them to explore their own ambivalence without judgment or confrontation.

Question 61: A specialty pharmacy must evaluate whether to accept a new limited distribution agreement for a hepatitis C antiviral. Which factor is LEAST relevant to this decision?

Pharmacy's existing patient population and payer mix
Reimbursement rates and financial viability of the contract
The pharmacist-in-charge's personal preference for the drug class (Correct answer)
Data reporting capabilities required by the manufacturer

Correct answer: The pharmacist-in-charge's personal preference for the drug class

Business decisions about limited distribution agreements should be driven by operational, financial, and patient-care factors, not the personal preferences of individual staff members.

Question 62: Which of the following is a required component of ALL REMS programs?

Timetable for submission of REMS assessments (Correct answer)
Healthcare provider certification
Medication guide
Patient enrollment registry

Correct answer: Timetable for submission of REMS assessments

A timetable for submission of REMS assessments to the FDA is required in every REMS program; all other elements are optional and included only when needed.

Question 63: Which of the following laboratory parameters is essential to obtain at baseline before initiating any direct-acting antiviral (DAA) regimen for Hepatitis C virus (HCV) infection?

Complete blood count (CBC) and a hepatic function panel (Correct answer)
Urinalysis for protein
Hepatitis A total antibody
Serum Vitamin D level

Correct answer: Complete blood count (CBC) and a hepatic function panel

Guidelines recommend several baseline laboratory tests within 6 months of starting DAA therapy, including a complete blood count (CBC), international normalized ratio (INR), and a hepatic function panel (albumin, bilirubin, ALT, AST). These tests help assess the patient's liver disease severity and overall health status before treatment.

Question 64: What is the importance of patient-centered care in counseling?

Forcing the patient to follow treatment.
Focusing only on the disease.
Focusing only on prescribing medications.
Incorporating the patient's values into treatment decisions (Correct answer)

Correct answer: Incorporating the patient's values into treatment decisions

Patient-centered care emphasizes treating the whole person, not just the disease. In counseling, this means actively listening to the patient's preferences, beliefs, and values, and integrating them into the shared decision-making process regarding their treatment plan. This approach respects patient autonomy, improves satisfaction, and enhances adherence by aligning care with what matters most to the individual.

Question 65: Which of the following best describes 'white bagging' in specialty pharmacy?

Dispensing a specialty drug to the patient who self-administers at home
Repackaging bulk specialty drugs into unit-dose containers
Providing drug samples to patients through a specialty pharmacy
Shipping a specialty drug directly to the physician office or infusion center for administration (Correct answer)

Correct answer: Shipping a specialty drug directly to the physician office or infusion center for administration

White bagging refers to specialty pharmacies dispensing medications directly to the provider (physician office or infusion center) rather than to the patient, who then receives administration at the provider site.

Question 66: A patient with phenylketonuria (PKU) is prescribed sapropterin (Kuvan). What is the standard method to assess response to this therapy?

Urine amino acid panel weekly
Genetic testing to confirm PAH mutation type before continuing
Brain MRI at 6 months
Blood phenylalanine level measured after a 1-month therapeutic trial (Correct answer)

Correct answer: Blood phenylalanine level measured after a 1-month therapeutic trial

Response to sapropterin is determined by measuring blood phenylalanine levels after a 1-month trial; only patients who respond (defined as a ≥30% reduction in phenylalanine) should continue therapy.

Question 67: Under most REMS programs with ETASU, a specialty pharmacy may NOT dispense a REMS medication if which condition exists?

The prescriber is not enrolled in the REMS program (Correct answer)
The patient has a prior authorization denial pending appeal
The patient is currently hospitalized
The prescription is written for a quantity exceeding a 90-day supply

Correct answer: The prescriber is not enrolled in the REMS program

If a REMS program requires prescriber certification, a pharmacy cannot legally dispense the medication unless the prescriber is enrolled and authorized under that REMS.

Question 68: In the context of a specialty pharmacy's patient management program, which activity best demonstrates the pharmacist's role in improving patient outcomes beyond simply measuring adherence?

Ensuring all prescriptions are filled and shipped within the pharmacy's turnaround time goals.
Generating a monthly report of the pharmacy's average Proportion of Days Covered (PDC).
Confirming the patient's shipping address and payment details before each refill.
Proactively assessing for side effects and collaborating with the prescriber to manage them. (Correct answer)

Correct answer: Proactively assessing for side effects and collaborating with the prescriber to manage them.

Improving outcomes requires more than ensuring the patient has the medication. Proactive clinical management, such as assessing and managing side effects, addresses a key therapy-related barrier to adherence. This collaborative action helps the patient tolerate the therapy, remain adherent, and achieve the desired clinical goals, directly impacting their health outcome. The other options are primarily operational or administrative tasks.

Question 69: Under URAC specialty pharmacy accreditation standards, how frequently must a pharmacist-conducted clinical review occur for patients on complex specialty therapies?

Every 90 days
Only at initiation of therapy
At every refill
Per URAC standards, at least annually with more frequent review based on clinical need (Correct answer)

Correct answer: Per URAC standards, at least annually with more frequent review based on clinical need

URAC requires at minimum an annual clinical pharmacist review, but standards call for more frequent review when patient complexity, adverse effects, or adherence issues warrant it.

Question 70: Which of the following medications is managed under the iPLEDGE REMS program?

Thalidomide
Isotretinoin (Correct answer)
Transmucosal immediate-release fentanyl
Clozapine

Correct answer: Isotretinoin

Isotretinoin is managed under iPLEDGE due to its severe teratogenicity; the program requires pregnancy testing, contraception, and monthly confirmations for females of childbearing potential.

Question 71: Which of the following is the PRIMARY purpose of a 'hub service' in the context of specialty pharmacy fulfillment?

To exclusively manage the cold chain logistics for temperature-sensitive medications.
To provide clinical trial enrollment services for new specialty drugs.
To act as the sole distributor for all limited distribution drugs.
To centralize and streamline patient access services like benefits investigation and prior authorization. (Correct answer)

Correct answer: To centralize and streamline patient access services like benefits investigation and prior authorization.

Hub services act as a central coordination point to help patients navigate the complex process of starting a specialty medication. Their primary function is to manage patient access services, which includes benefits verification, navigating the prior authorization process, and identifying financial assistance programs. This support helps to reduce delays and ensure patients can start therapy as quickly as possible.

Question 72: Which accreditation body specifically developed standards for specialty pharmacy practice in the United States?

ACHC
URAC (Correct answer)
The Joint Commission
PCAB

Correct answer: URAC

URAC was the first accreditation body to develop specialty pharmacy-specific standards and remains a leading accreditor in the specialty pharmacy space.

Question 73: Which government agency enforces drug safety regulations in the United States?

Centers for Disease Control and Prevention (CDC).
Environmental Protection Agency (EPA).
Food and Drug Administration (FDA) (Correct answer)
National Institutes of Health (NIH).

Correct answer: Food and Drug Administration (FDA)

The Food and Drug Administration (FDA) is the federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. It rigorously evaluates new drugs before they can be marketed and monitors their safety once approved, making it the primary enforcer of drug safety regulations.

Question 74: What is the primary purpose of a cold chain audit in specialty pharmacy operations?

To validate that copay assistance was correctly applied
To confirm that pharmacists are licensed in the patient's state
To ensure temperature-sensitive medications were maintained within required ranges during shipping (Correct answer)
To verify patient insurance eligibility

Correct answer: To ensure temperature-sensitive medications were maintained within required ranges during shipping

Cold chain audits verify that temperature-sensitive biologics and other specialty products remained within required temperature ranges from manufacturer to patient, protecting drug integrity and patient safety.

Question 75: Which of the following best describes the role of a CSP in managing a patient on ozanimod (Zeposia) for relapsing MS who develops macular edema?

Recommend over-the-counter lubricating eye drops and monitor symptoms
Advise the patient to continue the drug and schedule routine ophthalmology follow-up in 1 year
Switch the patient to a different S1P modulator without prescriber involvement
Recommend drug discontinuation and coordinate urgent ophthalmology evaluation, notifying the prescriber immediately (Correct answer)

Correct answer: Recommend drug discontinuation and coordinate urgent ophthalmology evaluation, notifying the prescriber immediately

Macular edema is a serious, vision-threatening adverse effect of ozanimod that requires prompt discontinuation and urgent ophthalmology evaluation; the CSP must notify the prescriber immediately.

Question 76: Which term describes a REMS requirement that restricts dispensing to only specially certified pharmacies?

Preferred pharmacy arrangement
Restricted distribution system (Correct answer)
Limited access dispensing protocol
Closed formulary network

Correct answer: Restricted distribution system

A restricted distribution system is an ETASU element that limits dispensing to certified specialty pharmacies, preventing dispensing at retail or non-enrolled outlets.

Question 77: Why is adherence to specialty drug therapy important in the management of chronic diseases?

It is not as important as other aspects of treatment.
It ensures the therapy remains effective and prevents complications (Correct answer)
It eliminates the need for additional medications.
It allows for faster recovery.

Correct answer: It ensures the therapy remains effective and prevents complications

Adherence to specialty drug therapy is paramount because these medications often treat serious, progressive chronic diseases. Consistent and correct medication use ensures the drug maintains therapeutic levels in the body, preventing disease progression and reducing the risk of complications. Non-adherence can lead to treatment failure and worsening health, making adherence critical for maximizing treatment effectiveness.

Question 78: A patient with severe plaque psoriasis has been stable on adalimumab for two years. They call the specialty pharmacy to report that their symptoms have been worsening over the last three months despite adherence to their injections. What is the most likely immunological reason for this secondary loss of response?

Increased drug clearance due to metabolic changes
Tachyphylaxis due to receptor downregulation
Formation of anti-drug antibodies (ADAs) (Correct answer)
Disease progression to a non-TNF-mediated pathway

Correct answer: Formation of anti-drug antibodies (ADAs)

A secondary loss of response to a tumor necrosis factor (TNF) inhibitor like adalimumab is often due to the development of anti-drug antibodies (ADAs). These antibodies can neutralize the drug's activity or increase its clearance, leading to subtherapeutic drug levels and reduced efficacy. Therapeutic drug monitoring to check for trough concentrations and ADA levels can help confirm this and guide subsequent treatment decisions.

Question 79: When measuring medication adherence using pharmacy claims data, which metric is generally preferred by quality organizations like the Pharmacy Quality Alliance (PQA) because it avoids overestimating adherence in patients who refill prescriptions early?

Pill Count Ratio (PCR)
Proportion of Days Covered (PDC) (Correct answer)
Self-Reported Adherence Rate (SRA)
Medication Possession Ratio (MPR)

Correct answer: Proportion of Days Covered (PDC)

Proportion of Days Covered (PDC) is often preferred over Medication Possession Ratio (MPR) because it caps the daily value at 1, preventing the numerator (days covered) from exceeding the denominator (days in the period) and thus avoiding an overestimation of adherence. Quality organizations like PQA and the National Committee for Quality Assurance (NCQA) use PDC for their performance measures.

Question 80: How does pharmacoeconomics influence healthcare policy?

It determines which medications are allowed.
It prioritizes patient demand for drugs.
It focuses only on reducing healthcare costs.
It guides policy decisions based on the cost-effectiveness of treatments (Correct answer)

Correct answer: It guides policy decisions based on the cost-effectiveness of treatments

Pharmacoeconomics significantly influences healthcare policy by providing evidence on the value and cost-effectiveness of various treatments and interventions. Policymakers use this data to make informed decisions about drug formularies, treatment guidelines, and resource allocation. This ensures that policies promote the use of therapies that offer the best health outcomes for the available budget, optimizing public health spending.

Question 81: What is the primary challenge in managing patients on specialty drug therapies?

Scheduling appointments for check-ups.
Ensuring adherence, managing side effects, and cost (Correct answer)
Managing simple medication regimens.
Providing routine tests and diagnostics.

Correct answer: Ensuring adherence, managing side effects, and cost

Specialty drug therapies are often complex, expensive, and associated with significant side effects, making patient adherence a major challenge. Specialty pharmacists must address these multifaceted issues by providing extensive patient education, support for side effect management, and assistance with financial burdens. These three factors are consistently identified as primary hurdles to successful treatment outcomes.

Question 82: Which of the following REMS programs uses a shared system that combines multiple manufacturers' products under one program?

S.T.E.P.S.
TIRF REMS Access (Correct answer)
Clozapine REMS
iPLEDGE

Correct answer: TIRF REMS Access

TIRF REMS Access is a shared REMS system that covers multiple manufacturers' transmucosal immediate-release fentanyl products under a single unified program.

Question 83: How can a pharmacist help a patient who is struggling with medication side effects?

Increasing the dose of the medication.
Providing no solutions.
Suggesting alternatives and adjusting the dosage (Correct answer)
Stopping the medication immediately.

Correct answer: Suggesting alternatives and adjusting the dosage

When a patient experiences medication side effects, a specialty pharmacist's role is to assess the severity and impact, then collaborate with the prescriber. They can suggest strategies to mitigate side effects, such as adjusting the dosage, changing the timing of administration, or recommending alternative therapies. This ensures the patient can continue treatment safely and effectively, as stopping medication immediately without consultation can be dangerous.

Question 84: A patient with Crohn's disease on a self-injectable biologic frequently misses doses. During a follow-up call, the patient states, "I just get so anxious about giving myself the shot, and it stings. I keep putting it off." This represents which type of adherence barrier?

Socioeconomic barrier
Therapy-related barrier (Correct answer)
System-related barrier
Patient-related barrier

Correct answer: Therapy-related barrier

The patient's non-adherence is directly linked to the characteristics of the therapy itself—the pain and anxiety associated with the self-injection process. This falls under the category of therapy-related barriers, which also includes side effects and regimen complexity.

Question 85: A patient with metastatic non-small cell lung cancer is being treated with pembrolizumab (Keytruda), an immune checkpoint inhibitor. After several cycles, the patient reports severe, persistent diarrhea (Grade 3 toxicity). According to current clinical guidelines for managing immune-related adverse events (irAEs), what is the MOST appropriate initial action for the specialty pharmacist to recommend?

Hold pembrolizumab and initiate high-dose corticosteroids. (Correct answer)
Initiate loperamide and continue pembrolizumab at the current dose.
Switch to a different immune checkpoint inhibitor, such as nivolumab.
Administer a dose of infliximab and continue pembrolizumab.

Correct answer: Hold pembrolizumab and initiate high-dose corticosteroids.

For Grade 3 or 4 immune-related adverse events (irAEs) such as severe colitis/diarrhea, standard management guidelines recommend holding or discontinuing the immune checkpoint inhibitor (ICI) and initiating high-dose corticosteroids (e.g., prednisone 1-2 mg/kg/day). Loperamide is insufficient for severe, immune-mediated diarrhea. Infliximab is typically reserved for steroid-refractory cases. Switching to another ICI is not recommended as irAEs are a class effect.

Question 86: What is one of the main barriers to medication adherence in patients with chronic diseases?

Complexity of the medication regimen (Correct answer)
Frequent checkups.
Lack of knowledge about the disease.
Having too many appointments.

Correct answer: Complexity of the medication regimen

Patients with chronic diseases often manage multiple medications, varying dosages, and specific administration instructions, leading to complex regimens. This complexity can overwhelm patients, making it difficult to remember doses, understand timing, and integrate medications into daily life. This significantly hinders adherence, making simplification and clear instructions key pharmacist interventions.

Question 87: A patient is being initiated on sofosbuvir/velpatasvir for Hepatitis C genotype 1. Their current medication list includes amlodipine, lisinopril, rosuvastatin 20 mg daily, and omeprazole 40 mg daily. Which of the following recommendations is most appropriate for the specialty pharmacist to make?

Switch omeprazole to famotidine 40 mg twice daily.
Discontinue rosuvastatin for the duration of Hepatitis C therapy.
Advise the patient to take the sofosbuvir/velpatasvir with food, four hours before the omeprazole. (Correct answer)
Recommend taking sofosbuvir/velpatasvir and omeprazole at the same time to improve adherence.

Correct answer: Advise the patient to take the sofosbuvir/velpatasvir with food, four hours before the omeprazole.

Velpatasvir's absorption is pH-dependent and is reduced by acid-lowering agents. Co-administration with proton-pump inhibitors (PPIs) like omeprazole is generally not recommended. However, if medically necessary, sofosbuvir/velpatasvir should be administered with food and taken 4 hours before a low dose of omeprazole (e.g., 20 mg).

Question 88: Under which federal law did the FDA gain formal authority to require REMS programs?

Prescription Drug User Fee Act (PDUFA) of 1992
Omnibus Budget Reconciliation Act (OBRA) of 1990
Drug Quality and Security Act (DQSA) of 2013
Food and Drug Administration Amendments Act (FDAAA) of 2007 (Correct answer)

Correct answer: Food and Drug Administration Amendments Act (FDAAA) of 2007

The FDAAA of 2007 granted the FDA explicit statutory authority to require REMS when necessary to ensure benefits of a drug outweigh its risks.

Question 89: A patient's commercial insurance plan utilizes a 'copay accumulator' program. The patient uses a manufacturer's copay card, which covers their $400 monthly cost for a specialty drug. What is the primary consequence of this program for the patient?

The patient will reach their annual deductible faster than anticipated.
The manufacturer's payment will be rejected by the specialty pharmacy.
The $400 paid by the manufacturer will not count toward the patient's annual deductible or out-of-pocket maximum. (Correct answer)
The health plan will reimburse the manufacturer for the $400 payment.

Correct answer: The $400 paid by the manufacturer will not count toward the patient's annual deductible or out-of-pocket maximum.

Copay accumulator programs are designed by payers to prevent the value of manufacturer copay assistance from counting toward a patient's deductible and annual out-of-pocket maximum. The plan 'accumulates' the manufacturer's payments but does not credit them to the patient's cost-sharing responsibilities, often resulting in an unexpected high cost for the patient once the manufacturer's assistance is exhausted.

Question 90: A specialty pharmacy is seeking URAC accreditation and is developing its Patient Management program. A core component of these standards requires the pharmacy to have documented processes for which of the following activities?

Establishing a marketing program to attract patients from competing pharmacies.
Compounding non-sterile preparations for off-label indications.
Measuring, monitoring, and reporting on clinical outcomes and patient satisfaction. (Correct answer)
Offering financial incentives to prescribers for detailed clinical notes.

Correct answer: Measuring, monitoring, and reporting on clinical outcomes and patient satisfaction.

URAC's Specialty Pharmacy Accreditation standards place a strong emphasis on demonstrating value and quality through patient-centered care. A fundamental requirement of the Patient Management (PM) standards is that the pharmacy must have a structured program to measure, monitor, analyze, and report on key performance metrics, including patient satisfaction, quality of life, and clinical outcomes.

Question 91: A patient with transthyretin amyloidosis (ATTR) is prescribed patisiran (Onpattro). How is this RNA interference (RNAi) therapy administered?

Subcutaneous injection monthly
Oral capsule taken daily
IV infusion every 3 weeks (Correct answer)
Intrathecal injection quarterly

Correct answer: IV infusion every 3 weeks

Patisiran is administered as an IV infusion every 3 weeks and requires premedication with corticosteroids, acetaminophen, and antihistamines to reduce infusion-related reactions.

Question 92: Under the clozapine REMS, absolute neutrophil count (ANC) monitoring is required because clozapine can cause which life-threatening condition?

Aplastic anemia
Thrombocytopenic purpura
Severe neutropenia (agranulocytosis) (Correct answer)
Hemolytic anemia

Correct answer: Severe neutropenia (agranulocytosis)

Clozapine can cause severe neutropenia (agranulocytosis), which can be fatal; the REMS mandates ANC monitoring before dispensing each prescription.

Question 93: A patient with spinal muscular atrophy (SMA) is prescribed nusinersen (Spinraza). What is a key specialty pharmacy role in managing this therapy?

Compounding the intrathecal formulation on-site
Dispensing the medication to the patient for self-administration at home
Coordinating benefits, site-of-care logistics, and patient support for this high-cost intrathecal therapy (Correct answer)
Performing the lumbar puncture procedure required for administration

Correct answer: Coordinating benefits, site-of-care logistics, and patient support for this high-cost intrathecal therapy

Nusinersen is an intrathecal injection administered by a neurologist; the specialty pharmacy's role centers on benefits investigation, authorization, site-of-care coordination, and patient/caregiver support.

Question 94: Which of the following oncology medications requires enrollment in a Risk Evaluation and Mitigation Strategy (REMS) program with Elements to Assure Safe Use (ETASU) due to its significant teratogenic risk?

Trastuzumab (Herceptin)
Rituximab (Rituxan)
Lenalidomide (Revlimid) (Correct answer)
Paclitaxel (Taxol)

Correct answer: Lenalidomide (Revlimid)

Lenalidomide (Revlimid) has a well-documented, high risk of severe, life-threatening birth defects and is subject to a strict REMS program. This program includes Elements to Assure Safe Use (ETASU) such as prescriber and pharmacy certification, and mandatory patient registry and pregnancy testing to prevent fetal exposure. The other medications listed do not have REMS programs with such stringent requirements.

Question 95: How does a specialty pharmacist manage the challenges of drug interactions in complex therapies?

By prescribing drugs without checking for interactions.
By adjusting dosages or changing therapies to minimize interactions (Correct answer)
By increasing the dosage of the most effective drugs.
By avoiding drug treatments altogether.

Correct answer: By adjusting dosages or changing therapies to minimize interactions

Specialty pharmacists possess in-depth knowledge of complex drug profiles and potential interactions, which are common in patients on multiple medications. They proactively identify and assess drug interaction risks, then collaborate with prescribers to modify treatment plans. This ensures patient safety and optimal therapeutic efficacy through careful monitoring and clinical judgment.

Question 96: Which specialty pharmacy accreditation standard most directly requires documentation of patient-specific clinical interventions?

HIPAA Privacy Rule
URAC/ACHC clinical management standards (Correct answer)
DEA Schedule II record-keeping requirements
USP <797> sterile compounding guidelines

Correct answer: URAC/ACHC clinical management standards

URAC and ACHC clinical management accreditation standards require specialty pharmacies to document patient-specific pharmacist interventions, including clinical assessments, counseling, and follow-up actions.

Question 97: A patient with hereditary angioedema (HAE) is prescribed subcutaneous icatibant (Firazyr) for acute attacks. What is the MOST important self-management counseling point?

Avoid subcutaneous injection sites near the abdomen
Inject at the first signs of an acute attack and seek emergency care if symptoms do not improve within 6 hours (Correct answer)
The drug must be refrigerated and cannot be carried for on-demand use
Take the medication daily as prophylaxis to prevent attacks

Correct answer: Inject at the first signs of an acute attack and seek emergency care if symptoms do not improve within 6 hours

Icatibant is indicated for on-demand treatment of acute HAE attacks; prompt injection at symptom onset is critical, and patients should seek emergency care if response is inadequate within 6 hours.

Question 98: A specialty pharmacy receives a new prescription for palbociclib (Ibrance) for a patient with HR+, HER2- metastatic breast cancer. The pharmacist notes the patient is also taking ketoconazole, a strong CYP3A4 inhibitor. What is the most appropriate clinical intervention?

Advise the patient to separate the administration times by at least 12 hours.
Recommend discontinuing ketoconazole and starting a non-interacting antifungal. (Correct answer)
Dispense both medications as prescribed with a warning to monitor for liver toxicity.
Recommend increasing the dose of palbociclib to overcome the interaction.

Correct answer: Recommend discontinuing ketoconazole and starting a non-interacting antifungal.

Palbociclib is a substrate of the CYP3A4 enzyme. Co-administration with strong CYP3A4 inhibitors like ketoconazole can significantly increase palbociclib concentrations and the risk of toxicity, such as neutropenia. The prescribing information recommends avoiding concomitant use. The best intervention is to recommend an alternative agent that does not inhibit CYP3A4. Dose reduction of palbociclib is an option if concomitant use is unavoidable, but switching the interacting agent is preferred.

Question 99: Which monitoring parameter is MOST critical for patients on alemtuzumab (Lemtrada) for multiple sclerosis?

Fasting lipid panel quarterly
Liver function tests monthly
Serum creatinine weekly
Thyroid function tests, complete blood count, and urinalysis monthly for 48 months after last dose (Correct answer)

Correct answer: Thyroid function tests, complete blood count, and urinalysis monthly for 48 months after last dose

Alemtuzumab carries risks of serious autoimmune conditions, including thyroid disorders, immune thrombocytopenia, and nephropathy, requiring monthly monitoring of thyroid function, CBC, and urinalysis for 4 years post-treatment.

Question 100: A specialty pharmacy receives a prior authorization (PA) denial for a biologic agent. What is the most appropriate FIRST step?

Switch to a formulary alternative without consulting the prescriber
Initiate a peer-to-peer review request with the prescriber's office (Correct answer)
Dispense the medication and bill later
Submit a grievance to the state insurance commissioner

Correct answer: Initiate a peer-to-peer review request with the prescriber's office

A peer-to-peer review allows the prescriber to discuss the clinical necessity directly with the payer's medical reviewer, which is typically the most effective first step in overturning a PA denial.

Question 101: A specialty pharmacist is reviewing a new prescription for ocrelizumab for a patient with relapsing-remitting multiple sclerosis. Which of the following baseline screenings is essential before the patient can receive their first dose?

Hepatitis B virus (HBV) screening (Correct answer)
Tuberculosis (TB) skin test or interferon-gamma release assay (IGRA)
Ophthalmologic exam including optical coherence tomography (OCT)
Lipid panel and liver function tests (LFTs)

Correct answer: Hepatitis B virus (HBV) screening

Ocrelizumab is an anti-CD20 monoclonal antibody that can cause reactivation of hepatitis B virus (HBV), potentially leading to fulminant hepatitis, liver failure, and death. Therefore, screening for HBV (including HBsAg and anti-HBc) is required before the first dose. While other tests may be part of general wellness or monitoring for other drug classes, HBV screening is a specific and critical prerequisite for initiating ocrelizumab.

Question 102: During an initial patient onboarding call, a pharmacist is discussing a new specialty therapy. Beyond explaining the medication's purpose and dosing, what is a key objective of this interaction to foster long-term success?

Setting realistic expectations for the treatment journey and building a strong patient relationship. (Correct answer)
Completing the call in under five minutes to improve pharmacy efficiency.
Obtaining consent to share data with pharmaceutical manufacturers.
Securing payment for the first month's co-pay.

Correct answer: Setting realistic expectations for the treatment journey and building a strong patient relationship.

The introductory call is a critical opportunity for the clinical pharmacist to do more than just provide instructions. It's a chance to set expectations for the patient's treatment journey, offer education, perform a medication profile review, and build a foundational relationship. This proactive engagement is crucial for long-term adherence and positive therapeutic outcomes.

Question 103: Which REMS program was established specifically for thalidomide (Thalomid)?

S.T.E.P.S. (System for Thalidomide Education and Prescribing Safety) (Correct answer)
SUPPORT (Systematic Utilization Program for Pregnancy and Outcomes Reporting)
T-REMS (Thalidomide Risk Evaluation and Monitoring System)
T-SAFE (Thalidomide Safety and Fertility Education)

Correct answer: S.T.E.P.S. (System for Thalidomide Education and Prescribing Safety)

The S.T.E.P.S. program was created for thalidomide due to its severe teratogenicity (historically causing phocomelia) and requires strict pregnancy prevention measures.

Question 104: What is the significance of a collaborative approach in patient management?

It delays the treatment process.
It forces the patient to follow the treatment plan.
It focuses on individual treatment from one provider.
It improves patient outcomes through teamwork (Correct answer)

Correct answer: It improves patient outcomes through teamwork

A collaborative approach in patient management involves healthcare professionals from different disciplines working together, sharing information, and coordinating care. This teamwork ensures a holistic view of the patient's needs, reduces medical errors, and optimizes treatment plans. Ultimately, it leads to better, more integrated care and improved health outcomes.

Question 105: Which of the following specialty pharmacy services is MOST critical for ensuring patient access to ultra-high-cost gene therapies such as betibeglogene spartacus (Zynteglo) for beta-thalassemia?

Biosimilar substitution to reduce cost
Daily automated refill reminders
Compounding the gene therapy in-house to reduce acquisition cost
Outcomes-based contracting facilitation and manufacturer financial assistance coordination (Correct answer)

Correct answer: Outcomes-based contracting facilitation and manufacturer financial assistance coordination

Gene therapies with multi-million-dollar price tags require specialty pharmacies to navigate outcomes-based contracts and manufacturer assistance programs to make therapy financially feasible for payers and patients.

Question 106: Which clinical finding would MOST warrant a CSP recommending a dose interruption or reduction in a patient on siponimod (Mayzent) for secondary progressive MS?

New onset of symptomatic bradycardia or second-degree AV block (Correct answer)
Mild headache reported in the first week of therapy
Mild elevation in liver enzymes at 3-month follow-up
Transient injection site erythema

Correct answer: New onset of symptomatic bradycardia or second-degree AV block

Siponimod, like other S1P modulators, can cause cardiac conduction effects; symptomatic bradycardia or AV block warrants dose interruption and urgent prescriber notification.

Question 107: A specialty pharmacy proposes to place a pharmacy-employed nurse liaison inside a large neurology clinic. The nurse's role would be to assist clinic staff with prior authorizations and patient education for any of the clinic's patients, regardless of which pharmacy they use. In return, the clinic agrees to send all of its specialty prescriptions to that pharmacy. This arrangement MOST likely violates which federal law?

The Stark Law (Physician Self-Referral Law)
The Drug Supply Chain Security Act (DSCSA)
The Anti-Kickback Statute (AKS) (Correct answer)
The Health Insurance Portability and Accountability Act (HIPAA)

Correct answer: The Anti-Kickback Statute (AKS)

The Anti-Kickback Statute (AKS) is a federal criminal law prohibiting the exchange of anything of value to induce or reward the referral of federal health care program business. Providing a 'free' employee to a prescriber's office constitutes remuneration intended to induce referrals, which is a classic example of a potential AKS violation. HIPAA deals with patient privacy, DSCSA with drug supply chain integrity, and the Stark Law with physician self-referral to entities where they have a financial interest.

Question 108: What is the importance of understanding pharmacoeconomics for healthcare professionals?

It reduces the need for healthcare education.
It increases medication prices.
It focuses only on cost reduction.
It helps make informed decisions on therapy, balancing cost and outcomes (Correct answer)

Correct answer: It helps make informed decisions on therapy, balancing cost and outcomes

Understanding pharmacoeconomics is essential for healthcare professionals because it empowers them to make informed decisions about patient care that balance clinical effectiveness with economic considerations. This knowledge helps in selecting therapies that offer the best outcomes for patients while being mindful of resource constraints and healthcare system sustainability. Ultimately, it leads to more efficient and equitable healthcare delivery.

Question 109: A specialty pharmacy receives a prescription for a temperature-sensitive biologic that must be maintained between 2°C and 8°C. The medication is being shipped overnight to a patient in a different state. Which of the following is the MOST critical component to ensure medication integrity upon arrival?

Placing a 'Refrigerate on Arrival' sticker on the box.
Including a temperature monitoring device in the package. (Correct answer)
Using a large, well-insulated container.
Selecting the fastest possible shipping option.

Correct answer: Including a temperature monitoring device in the package.

While all options are good practices, including a temperature monitoring device is the most critical component for ensuring and verifying the integrity of a cold chain shipment. This device provides a record of the temperature throughout transit, confirming whether any excursions outside the required 2°C to 8°C range occurred. This data is essential for determining if the medication is safe and effective to dispense to the patient upon arrival.

Question 110: Which orphan drug act provision is MOST relevant to specialty pharmacies dispensing rare disease therapies?

It requires specialty pharmacies to dispense orphan drugs at no charge
It grants manufacturers market exclusivity for 7 years, which often results in limited competition and high drug prices that specialty pharmacies must navigate with payers (Correct answer)
It allows specialty pharmacies to compound orphan drugs without FDA oversight
It mandates that orphan drugs bypass FDA approval

Correct answer: It grants manufacturers market exclusivity for 7 years, which often results in limited competition and high drug prices that specialty pharmacies must navigate with payers

The Orphan Drug Act's 7-year market exclusivity limits generic/biosimilar competition, contributing to high costs that specialty pharmacies must address through prior authorizations, manufacturer assistance programs, and payer negotiations.

Question 111: A CSP is reviewing adherence data and finds that 30% of patients on an oral specialty oncology agent have not refilled within 7 days of their expected refill date. Which intervention is MOST appropriate?

Implement a proactive outreach program with pharmacist-led adherence counseling (Correct answer)
Reduce the days supply dispensed to force more frequent contact
Discontinue the patients from the program and notify the prescriber
Automatically dispense the next refill without patient contact

Correct answer: Implement a proactive outreach program with pharmacist-led adherence counseling

Proactive outreach with pharmacist-led adherence counseling addresses barriers to refill, such as side effects, cost, or misunderstanding of the regimen, to improve outcomes and adherence rates.

Question 112: A specialty pharmacist is counseling a patient who is starting on daily oral emtricitabine/tenofovir alafenamide (F/TAF) for HIV pre-exposure prophylaxis (PrEP). Which of the following is a critical initial assessment that must be confirmed before dispensing the first fill?

A baseline bone mineral density (BMD) scan.
The patient's complete blood count (CBC) from the last 6 months.
The patient's hepatitis C virus (HCV) antibody status.
A negative HIV test result at or very near the time of initiation. (Correct answer)

Correct answer: A negative HIV test result at or very near the time of initiation.

It is imperative to confirm that a patient is HIV-negative before starting PrEP. Initiating a two-drug regimen like F/TAF in a person with undiagnosed acute or established HIV can lead to the development of drug resistance, complicating future treatment options.

Question 113: The TIRF REMS Access program applies to which class of medications?

Transdermal intermediate-release fentanyl patches
Transmucosal immediate-release fentanyl products (Correct answer)
Timed-release intrathecal fentanyl devices
Topical immunosuppressive fentanyl formulations

Correct answer: Transmucosal immediate-release fentanyl products

TIRF REMS Access covers transmucosal immediate-release fentanyl products (e.g., lozenges, buccal films, nasal sprays) due to serious risk of misuse, abuse, and fatal overdose.

Question 114: What is HIPAA, and why is it important in healthcare?

It increases healthcare costs.
It is a law that regulates healthcare provider salaries.
It protects patient privacy and secures health information (Correct answer)
It mandates drug pricing regulations.

Correct answer: It protects patient privacy and secures health information

HIPAA (Health Insurance Portability and Accountability Act) is a federal law that establishes national standards to protect sensitive patient health information from being disclosed without the patient's consent or knowledge. Its importance lies in safeguarding patient privacy, maintaining trust in the healthcare system, and ensuring the secure handling of protected health information (PHI).

Question 115: Which metric is most commonly used to evaluate specialty pharmacy dispensing efficiency and patient safety?

Medication error rate per 1,000 prescriptions (Correct answer)
Dispense as written (DAW) rate
Days on hand (DOH)
Net promoter score (NPS)

Correct answer: Medication error rate per 1,000 prescriptions

Medication error rate per 1,000 prescriptions is a key safety metric that specialty pharmacies track to identify process breakdowns and prioritize quality improvement efforts.

Question 116: A 35-year-old male patient with HIV is diagnosed with latent tuberculosis infection (LTBI). His current antiretroviral therapy (ART) is Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide). Which of the following is a preferred and appropriate treatment regimen for his LTBI?

Levofloxacin 750 mg daily for 6 months
Isoniazid 300 mg daily for 9 months (Correct answer)
Rifampin 600 mg daily for 4 months
Isoniazid and rifapentine once weekly for 3 months (3HP)

Correct answer: Isoniazid 300 mg daily for 9 months

Nine months of daily isoniazid is a standard and effective treatment for latent TB infection in people with HIV and can be co-administered with any antiretroviral regimen, including Biktarvy®. Rifamycin-based regimens (like those containing rifampin or rifapentine) have significant drug-drug interactions with many ART components, including integrase inhibitors like bictegravir, making isoniazid monotherapy a safer and preferred choice in this scenario.

Question 117: Which specialty pharmacy action is required when a REMS program with ETASU mandates pharmacist certification?

The pharmacy must submit quarterly adverse event reports to the FDA
The pharmacy must enroll in the REMS program before dispensing the medication (Correct answer)
The pharmacy must obtain written prescriber authorization for each prescription
The pharmacy must dispense only a 30-day supply of the medication

Correct answer: The pharmacy must enroll in the REMS program before dispensing the medication

When ETASU require pharmacy certification, the specialty pharmacy must formally enroll in the specific REMS program before it is authorized to dispense that medication.

Question 118: What is the main advantage of a centralized clinical call center model within a large specialty pharmacy organization?

It provides consistent, standardized patient counseling and clinical monitoring at scale (Correct answer)
It allows non-pharmacist staff to make clinical decisions independently
It removes the requirement for REMS certification
It eliminates the need for pharmacist oversight of dispensing

Correct answer: It provides consistent, standardized patient counseling and clinical monitoring at scale

A centralized clinical call center enables specialty pharmacies to deliver standardized, high-quality pharmacist counseling and monitoring to large patient populations while maintaining compliance with accreditation standards.

Question 119: Which of the following biologic DMARDs used for rheumatoid arthritis works by inhibiting T-cell activation through binding to CD80 and CD86?

Abatacept (Correct answer)
Tocilizumab
Rituximab
Adalimumab

Correct answer: Abatacept

Abatacept is a T-cell co-stimulation modulator. It selectively binds to CD80 and CD86 on antigen-presenting cells, thereby blocking the required co-stimulatory signal needed for T-cell activation. Adalimumab is a TNF-alpha inhibitor, rituximab is an anti-CD20 monoclonal antibody that depletes B-cells, and tocilizumab is an IL-6 receptor antagonist.

Question 120: What is the purpose of cost-benefit analysis in pharmacoeconomics?

To increase treatment costs.
To simplify reimbursement procedures.
To evaluate patient satisfaction.
To compare the benefits of a drug to its costs (Correct answer)

Correct answer: To compare the benefits of a drug to its costs

Cost-benefit analysis in pharmacoeconomics aims to compare the total monetary costs of a drug or intervention with its total monetary benefits. Unlike cost-effectiveness, which measures benefits in natural units (e.g., life-years), cost-benefit analysis converts all outcomes, including health benefits, into monetary terms. This allows for a direct comparison to determine if the monetary benefits outweigh the costs, providing a clear economic justification for an intervention.

Question 121: What is the primary goal of specialty drug therapies in managing complex diseases?

To prevent recurrence.
To manage symptoms and improve quality of life (Correct answer)
To cure the disease.
To eliminate the need for other treatments.

Correct answer: To manage symptoms and improve quality of life

Specialty drug therapies are often used for complex, chronic, or rare diseases that require specialized handling, administration, and monitoring. While they may not always offer a cure, their primary goal is to effectively manage disease symptoms, slow progression, prevent complications, and ultimately enhance the patient's overall quality of life.

Question 122: A specialty pharmacy contracts with a Federally Qualified Health Center (FQHC) to dispense medications to its eligible patients. This arrangement allows the FQHC to generate savings to support its services. Which federal program enables this?

The 340B Drug Pricing Program. (Correct answer)
The Medicaid Drug Rebate Program.
The Prescription Drug Marketing Act.
The Medicare Part D Coverage Gap Discount Program.

Correct answer: The 340B Drug Pricing Program.

The 340B Drug Pricing Program is a U.S. federal government program that requires drug manufacturers to provide outpatient drugs to eligible health care organizations, known as 'covered entities' (like FQHCs), at significantly reduced prices. Covered entities can partner with specialty pharmacies ('contract pharmacies') to dispense these drugs, and the savings generated are used to support patient care and expand services.

Question 123: A physician's office faxes a specialty prescription to the pharmacy, but it is missing the patient's insurance information and diagnosis code. What is the most appropriate next action for the intake coordinator?

Assume the medication is not covered and inform the patient they will be responsible for the full cost.
Proactively contact the prescriber's office to obtain the complete and accurate information. (Correct answer)
Reject the prescription and ask the physician's office to resend it.
Contact the patient directly to obtain the missing information.

Correct answer: Proactively contact the prescriber's office to obtain the complete and accurate information.

To ensure timely initiation of therapy and avoid delays, the specialty pharmacy team should proactively reach out to the prescriber's office to clarify and obtain any missing information, such as diagnosis codes or insurance details. This collaborative approach is a key service provided by specialty pharmacies to support both patients and providers. Rejecting the prescription or placing the burden entirely on the patient would create unnecessary delays.

Question 124: A specialty pharmacy has a contract pharmacy relationship with a 340B-covered entity. To maintain compliance and prevent diversion, what is the most critical responsibility of the pharmacy?

Using a separate wholesaler for 340B drug purchases than for its own GPO purchases.
Reporting all 340B dispensing activity to the state board of pharmacy on a monthly basis.
Ensuring the 340B-acquired drugs are dispensed only to individuals who are eligible patients of the covered entity. (Correct answer)
Charging all patients the same acquisition cost for the medication.

Correct answer: Ensuring the 340B-acquired drugs are dispensed only to individuals who are eligible patients of the covered entity.

The core principle of the 340B program is to provide discounted drugs to eligible patients of covered entities. Diversion, a major compliance violation, occurs when a 340B-purchased drug is provided to an individual who does not meet the HRSA definition of an eligible patient. The covered entity is ultimately responsible, but the contract pharmacy must have systems in place to ensure 340B drugs are not diverted.

Question 125: What does the Controlled Substances Act (CSA) regulate?

It oversees food labeling.
It sets rules for clinical trials.
It regulates controlled substances to prevent misuse and abuse (Correct answer)
It regulates drug pricing.

Correct answer: It regulates controlled substances to prevent misuse and abuse

The Controlled Substances Act (CSA) is a federal law that categorizes drugs based on their potential for abuse and medical utility. It establishes a regulatory framework for the manufacture, distribution, and dispensing of controlled substances. The CSA aims to prevent their diversion, misuse, and abuse, thereby protecting public health and safety.

Question 126: What is the primary focus of pharmacoeconomics in healthcare?

To reduce the need for medication.
To reduce the overall cost of healthcare.
To increase healthcare spending.
To evaluate the cost-effectiveness of treatments (Correct answer)

Correct answer: To evaluate the cost-effectiveness of treatments

Pharmacoeconomics is a field that applies economic principles to the study of pharmaceutical products and healthcare interventions. Its primary goal is to assess the value of treatments by comparing their costs to their clinical outcomes and benefits. This evaluation helps healthcare systems make informed decisions about resource allocation and treatment adoption, ensuring resources are used efficiently.

Question 127: What is the primary consequence for a specialty pharmacy that dispenses a REMS-required medication without complying with REMS requirements?

The pharmacy is automatically removed from the manufacturer's preferred network
The pharmacy must issue a voluntary recall of the dispensed medication
The pharmacy must only notify the prescriber of the non-compliance
The pharmacy may face FDA enforcement action, including warning letters, injunctions, or civil monetary penalties (Correct answer)

Correct answer: The pharmacy may face FDA enforcement action, including warning letters, injunctions, or civil monetary penalties

Non-compliance with REMS requirements can subject a pharmacy to FDA enforcement actions including warning letters, injunctions, seizures, and civil monetary penalties.

Question 128: A 45-year-old male with Crohn's disease is receiving an infliximab infusion at an infusion center. 15 minutes into the infusion, he complains of flushing, itching, and shortness of breath. The nurse stops the infusion. What is the most appropriate immediate next step?

Obtain trough and anti-drug antibody levels
Administer epinephrine immediately
Restart the infusion at a slower rate
Administer intravenous corticosteroids and antihistamines (Correct answer)

Correct answer: Administer intravenous corticosteroids and antihistamines

For a mild-to-moderate infusion-related reaction (IRR), the standard procedure is to stop the infusion and provide supportive care, which typically includes administering intravenous corticosteroids (e.g., methylprednisolone) and antihistamines (e.g., diphenhydramine). Epinephrine is reserved for severe, anaphylactic reactions. Restarting the infusion without treatment is inappropriate, and while lab levels are important for long-term management, they are not the immediate priority during an acute reaction.

Question 129: Why is regulatory compliance crucial for healthcare professionals?

To reduce the number of healthcare workers.
To prevent legal issues and maintain patient safety (Correct answer)
To limit patient access to treatments.
To increase pharmaceutical profits.

Correct answer: To prevent legal issues and maintain patient safety

Regulatory compliance is crucial for healthcare professionals because it ensures they operate within legal and ethical boundaries, thereby preventing malpractice lawsuits, fines, and loss of licensure. More importantly, adherence to regulations, such as those for patient privacy, drug safety, and quality standards, directly safeguards patient well-being and promotes high-quality care.

Question 130: A patient with rheumatoid arthritis receives a physician-administered intravenous biologic in a hospital outpatient clinic. The specialty pharmacy supplies the medication to the clinic. Under which benefit is this drug MOST likely to be reimbursed, and what is the common payment methodology used by Medicare for it?

Medical Benefit; based on Average Sales Price (ASP) plus a percentage. (Correct answer)
Pharmacy Benefit; based on Wholesale Acquisition Cost (WAC) plus a dispensing fee.
Medical Benefit; based on a flat per-member-per-month capitation fee.
Pharmacy Benefit; based on Average Wholesale Price (AWP) minus a percentage.

Correct answer: Medical Benefit; based on Average Sales Price (ASP) plus a percentage.

Drugs administered by a healthcare professional in a clinical setting, such as a hospital outpatient department or a physician's office, are typically covered under the patient's medical benefit, not the pharmacy benefit. The standard reimbursement methodology used by Medicare Part B for these drugs is based on the Average Sales Price (ASP) plus a percentage add-on (currently 6%).

Question 131: What is a common method used in pharmacoeconomics to assess the economic burden of a disease?

Tracking the cost of treatments only.
Using Quality-Adjusted Life Years (QALYs) (Correct answer)
Measuring the number of hospital visits.
Focusing on patient satisfaction.

Correct answer: Using Quality-Adjusted Life Years (QALYs)

Quality-Adjusted Life Years (QALYs) are a common metric used in pharmacoeconomics to measure the health outcomes of interventions, taking into account both the quantity and quality of life. A QALY combines the years of life gained from a treatment with a weighting for the quality of those years, where 1 QALY equals one year of perfect health. This allows for a standardized comparison of the economic burden and effectiveness of different diseases and treatments.

Question 132: What is a key pharmacist responsibility related to REMS documentation in a specialty pharmacy setting?

Maintaining records of REMS-required patient counseling, monitoring data, and dispense confirmations for FDA audit purposes (Correct answer)
Submitting individual prescription data to the FDA within 24 hours of each dispense
Reporting all REMS-covered prescriptions to the DEA regardless of controlled substance status
Providing written attestation to the manufacturer after each patient's first fill only

Correct answer: Maintaining records of REMS-required patient counseling, monitoring data, and dispense confirmations for FDA audit purposes

Specialty pharmacies must maintain complete REMS-related records—including counseling documentation, monitoring data, and dispense confirmations—that demonstrate compliance and are available for FDA audits.

Question 133: A patient is prescribed an oral oncolytic that is covered under their pharmacy benefit. The reimbursement that the specialty pharmacy receives from the PBM is most commonly based on which of the following models?

A discount off a benchmark price, such as Average Wholesale Price (AWP) or Wholesale Acquisition Cost (WAC), plus a dispensing fee. (Correct answer)
A bundled payment covering the drug, counseling, and all ancillary supplies.
Average Sales Price (ASP) plus a 6% administration fee.
A per-diem rate for each day the patient is on therapy.

Correct answer: A discount off a benchmark price, such as Average Wholesale Price (AWP) or Wholesale Acquisition Cost (WAC), plus a dispensing fee.

For self-administered drugs dispensed by a pharmacy and billed under the pharmacy benefit, the traditional reimbursement model is fee-for-service. This typically involves the PBM paying the pharmacy based on a contracted discount off a list price benchmark like AWP or WAC, plus a negotiated professional dispensing fee. ASP-based reimbursement is used for drugs billed under the medical benefit (e.g., Medicare Part B).

Question 134: A specialty pharmacy aims to enhance its adherence program for patients taking oral medications for pulmonary arterial hypertension. Which of the following technology-based interventions is most likely to improve patient outcomes?

Providing a link to the manufacturer's website on the prescription label.
Mailing a quarterly newsletter with general information about the disease state.
Requiring patients to call a hotline to confirm they have received their medication shipment each month.
Implementing a mobile application with personalized dose reminders, educational content, and a feature for tracking side effects. (Correct answer)

Correct answer: Implementing a mobile application with personalized dose reminders, educational content, and a feature for tracking side effects.

Interactive, patient-centered technology like a comprehensive mobile app is most effective. It actively engages the patient with personalized reminders, provides easily accessible information, and allows for self-monitoring, which can improve both adherence and self-management skills, leading to better outcomes. Passive or burdensome interventions are less effective.

Question 135: What does REMS stand for in the context of the FDA?

Required Elements and Medication Surveillance
Regulatory Enforcement and Monitoring System
Risk Evaluation and Mitigation Strategy (Correct answer)
Restricted Entry and Monitoring Standards

Correct answer: Risk Evaluation and Mitigation Strategy

REMS stands for Risk Evaluation and Mitigation Strategy, which are FDA-required programs to ensure certain drugs with serious safety risks are used appropriately.

Question 136: A specialty pharmacist is counseling a patient starting on an interleukin-6 (IL-6) inhibitor, such as tocilizumab or sarilumab, for rheumatoid arthritis. In addition to the risk of serious infections, which of the following laboratory parameters requires routine monitoring with this class of medication?

Absolute neutrophil count (ANC) and liver function tests (LFTs) (Correct answer)
Serum uric acid
Creatine phosphokinase (CPK)
Serum creatinine and BUN

Correct answer: Absolute neutrophil count (ANC) and liver function tests (LFTs)

Interleukin-6 (IL-6) inhibitors are associated with hematologic and hepatic adverse effects. Routine monitoring of the absolute neutrophil count (ANC) for neutropenia and liver function tests (LFTs) for transaminitis is required. Dose adjustments or discontinuation may be necessary based on these lab values. Hyperlipidemia is also a concern, but neutropenia and LFT elevations are key monitoring parameters that can lead to immediate changes in therapy.

Question 137: A specialty pharmacist is reviewing a prescription for lenalidomide (Revlimid). What REMS program governs its dispensing?

LEN-SAFE program
IMiDs REMS Consortium
REVLIMID REMS (formerly RevAssist) (Correct answer)
LENALID REMS Access

Correct answer: REVLIMID REMS (formerly RevAssist)

Lenalidomide is dispensed under the REVLIMID REMS (formerly RevAssist), which requires patient enrollment, pregnancy prevention for females, and confirmation of negative pregnancy tests before each dispense.

Question 138: Which of the following is a common side effect of biologic drugs?

Increased risk of infections (Correct answer)
Increased appetite.
Hair loss.
Frequent headaches.

Correct answer: Increased risk of infections

Biologic drugs work by targeting specific parts of the immune system, which can suppress the body's natural defenses. This immunosuppression makes patients more susceptible to various infections, ranging from common colds to more serious opportunistic infections. Specialty pharmacists educate patients on infection prevention and monitor for signs of infection.

Question 139: A new patient expresses significant anxiety about the high cost of their specialty medication during the onboarding call. What is the specialty pharmacy's MOST appropriate response?

Inform the patient about the pharmacy's financial assistance services and offer to investigate manufacturer co-pay programs or foundation support. (Correct answer)
Suggest the patient look for a different, cheaper medication.
Advise the patient to call their insurance company directly without further assistance.
Inform the patient that the pharmacy is not responsible for medication costs.

Correct answer: Inform the patient about the pharmacy's financial assistance services and offer to investigate manufacturer co-pay programs or foundation support.

A key service of specialty pharmacies is helping patients navigate financial barriers. The appropriate response is to acknowledge the patient's concern and proactively offer to help by exploring financial assistance options, such as manufacturer co-pay cards, patient assistance programs (PAPs), and grants from charitable foundations.

Question 140: A specialty pharmacy receives a new prescription for a patient recently diagnosed with a complex, rare disease. Which of the following is the MOST critical initial step in the patient intake process?

Providing the patient with a comprehensive list of all potential side effects.
Conducting a benefits investigation and verifying insurance coverage. (Correct answer)
Scheduling the first delivery of the medication.
Dispensing a 7-day supply to initiate therapy immediately.

Correct answer: Conducting a benefits investigation and verifying insurance coverage.

Before any medication can be dispensed or delivered, the specialty pharmacy must first conduct a thorough benefits investigation to verify the patient's insurance coverage and determine if a prior authorization is required. This step is crucial for identifying the patient's financial responsibility, preventing claim rejections, and avoiding significant delays in therapy.

Question 141: Which component of the patient onboarding process is specifically designed to ensure that a prescribed specialty drug is medically necessary and appropriate for the patient's condition according to their health plan?

Welcome call scripting.
Patient satisfaction survey.
Prior Authorization (PA). (Correct answer)
Delivery scheduling.

Correct answer: Prior Authorization (PA).

Prior authorization is a utilization management process used by insurance companies to ensure that a prescribed medication is medically necessary, safe, and cost-effective before it is covered. Specialty pharmacies dedicate significant resources to managing the PA process, which involves collecting clinical documentation from the prescriber to justify the treatment to the payer.

Certified Specialty Pharmacist (CSP) Exam

The CSP examination certifies pharmacists who demonstrate advanced knowledge and expertise in the specialized practice of specialty pharmacy.

175

Questions

240 min

Time Limit

70%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds